Margo Heath-Chiozzi, SVP of Regulatory Affairs at Celldex Therapeutics, Inc. (CLDX), sold 600 shares at $41.71 ($25K) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Scheduled sale ($25k) by SVP of Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| CLDX | SELL | 2021-12-10 | $24K | — | Filing → |
| CLDX | BUY | 2020-06-10 | $3K | — | Filing → |